New oral antiviral drug to be used for treatment of COVID-19
By Zhang Zhihao |
chinadaily.com.cn |
Updated: 2023-03-23 19:18
Share
Share - WeChat
The National Medical Products Administration has recently granted conditional market approval for an oral antiviral drug RAY1216 in a bid to treat COVID-19.
The drug can be used to treat adults with mild and moderate symptoms of COVID-19, but it must be taken under medical supervision, the administration said.
RAY1216 is a drug developed by Guangdong Zhongsheng Pharmaceutical.
- Mainland scholar discloses fallacies in Lai's separatist narrative on 'unity'
- University's expulsion of female student ignites online debate
- 4,000 hiking enthusiasts hit rugged trails in Chongqing
- Creative fireworks show held in China's 'fireworks capital'
- Chinese scientists achieve net-negative greenhouse gas emissions via electrified catalysis
- At the gateway to China's resistance, memories of war echo 88 years on
